Article
Tumor suppressor SPOP ubiquitinates and degrades EglN2 to compromise growth of prostate cancer cells.
Cancer letters - 1 Apr 2017
Zhang Linli, Peng Shan, Dai Xiangpeng, Gan Wenjian, Nie Xin, Wei Wenyi, Hu Guoqing, Guo Jianping
Abstract excerpt
EglN prolyl hydroxylases, a family of oxygen-sensing enzymes, hydroxylate distinct proteins to modulate diverse physiopathological signals. Aberrant regulations of EglNs result in multiple human diseases, including cancer. Different from EglN1 which function largely depends on the role of hypoxia-induce factor alpha (HIFα) in tumors, the functional significance and the upstream regulatory mechanisms of EglN2,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
